Table 1.
Clinical characteristics of patient subgroups.
| M/F | Age, years median±SD | Platelet count ×109/L, median±SD | Additional data | |
|---|---|---|---|---|
| FAM | 6/6 | 42.5±12 | 65±14 | 10 BS 2 MH |
| ITP | 5/10 | 38±16 | 41.6±22 | - |
| MDS | 5/3 | 60±12 | 44±24 | 5 RA 3 RCMD |
| Hypo | 4/4 | 62±15 | 38±19 | 3 AA 5 CT |
| Healthy controls | 9/6 | 36.5±12.2 | 261.5±55.5 | - |
| MGUS | 3/2 | 59±7 | 257±53.2 | - |
| ET | 8/4 | 50±8 | 818±318 | All V617F mutated |
AA, aplastic anemia; CT, Chemotherapy-induced thrombocytopenia; BS, Bernard-Soulier; MGUS, monoclonal gammopathy of undetermined significance; MH, May-Hegglin; RA: refractory anemia; RCMD, refractory anemia with multilineage dysplasia.